Weedstocks Newswire Feed
GATINEAU, Québec, 25 sept. 2018 (GLOBE NEWSWIRE) -- Hexo Corp. (« Hexo » ou la « Société ») (TSX: Hexo) est ravie d’annoncer l’expédition de sa première commande destinée au marché adulte du cannabis au Canada.
Il s’agit d’un autre exemple de la réalisation, par la Société, de la promesse faite aux actionnaires et consommateurs de fournir des produits HEXO novateurs et faciles à utiliser partout au Canada. « C’est un moment historique pour HEXO, a déclaré Sonia Isabel, vice-présidente des ventes d’HEXO. Nous sommes très fiers de toutes nos équipes qui ont travaillé d’arrache-pied jusqu’à présent. Cela ne fait que commencer! Nous continuerons à fournir des produits et des expériences client de qualité supérieure pendant notre expansion au Canada et au-delà des frontières. »
HEXO a signé un contrat d’un milliard de dollars sur cinq ans qui en fait le fournisseur privilégié de la Société québécoise du cannabis, en plus d’obtenir un contrat de distribution en ligne au Québec. HEXO a également conclu des accords pour fournir du cannabis à usage adulte en Ontario et en Colombie-Britannique. Enfin, la Société a acquis une importante participation dans Fire & Flower, un grand détaillant de cannabis destiné aux adultes qui est en passe de conquérir une part importante du marché canadien et de desservir tous les segments du marché au Canada dans un avenir proche.
À propos de HEXO Corp.
HEXO Corp. crée et distribue des produits novateurs, faciles à utiliser et à comprendre pour servir le marché canadien du cannabis. L'un des producteurs les moins chers au pays, HEXO augmente rapidement sa capacité de production dans la perspective du marché du cannabis chez les adultes. La Société exploite actuellement une capacité de production de plus de 310 000 pieds carrés et a un autre agrandissement de 1 000 000 pieds carrés présentement en construction qui devrait être terminé d'ici la fin de l'année. HEXO desservira le marché de l'usage adulte sous la marque HEXO, tout en continuant à servir ses clients du cannabis médical par l'entremise de la célèbre marque Hydropothecary.
TORONTO, Sept. 25, 2018 /CNW/ - GreenSpace Brands Inc. ("GreenSpace" or "the Company") (TSXV: JTR) is pleased to announce that it has officially become a Certified B Corporation ("B Corp"). B Corps are a new kind of company that use the power of business as a force for good. GreenSpace joins the rapidly growing movement of more than 2,500 Certified B Corps from 130 industries, across 50 countries including companies like Patagonia, Danone, and Ben & Jerry's.
Certified B Corps believe it is important to include additional considerations on how success is measured in the business world. B Corps voluntarily meet high standards for social and environmental performance, accountability and transparency. As a Certified B Corp, GreenSpace will measure and manage the impact of its business on its employees, community and the environment with close to as much rigor as it manages and monitors its profits.
"From day one the team has believed that working at GreenSpace is about building something bigger than ourselves. We continue to focus on having a positive impact on our communities, the environment and our employees, as we believe through these initiatives we can deliver on our promise of better to more, and ultimately drive returns for our shareholders. It truly is an honour to be a part of such a great community of B Corp members." said Aaron Skelton, COO of GreenSpace Brands Inc.
"We are thrilled to welcome GreenSpace to our Canadian B Corp movement. We're excited to see larger companies taking the B Corp assessment and holding themselves to a rigorous standard of social and environment impact. The work of creating a more shared and durable prosperity is a shared effort, and we're excited to have GreenSpace join other business leaders driving this forward." said Kasha Huk, Country Manager of B Lab Canada.
About GreenSpace Brands Inc.
PUF Ventures Announces $40 Million Investment for Development of Large Scale Cannabis Cultivation Facility in Delta, B.C.
VANCOUVER, Sept. 25, 2018 /CNW/ - PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, and Delta Organic Cannabis Corp. ("DOCC"), a privately held Toronto-based cannabis investment company backed by preeminent leaders in Canadian cannabis enterprise, today signed an Equity Participation and Earn-In Agreement (the "Agreement") which provides for up to $40 million in investment at a price of $2.24 per PUF share for the development of a large-scale, commercial medical cannabis cultivation operation in Delta, British Columbia. The proceeds of the subscriptions shall be used exclusively to develop the Delta propagation facility (the "Delta Facility") consisting of 2,200,000 sq. feet of illuminated greenhouse space and 1,700,000 sq. feet of "ebb and flood" irrigation space. This is an arm's length transaction and no finder's fees are to be paid.
Derek Ivany, President & CEO of PUF, commented: "On behalf of our entire team, I am extremely pleased to announce the achievement of this marquee milestone for PUF. We have constantly strived to deliver shareholder value and I believe this significant financial commitment in support of our state-of-the-art greenhouse project in British Columbia demonstrates the tremendous value of this endeavour. In comparison to other existing large-scale cannabis cultivation facilities, the finalization of this project catapults PUF into the upper echelon of participants in the space." Mr. Ivany continued, "This sizeable financial commitment will provide enough capital to allow us to focus the majority of our strategy on high quality cannabis flowering while also still advancing the propagation service aspect of our business thus creating a more diversified revenue mix."
Christopher MacIntyre, President of DOCC, stated: "PUF has secured one of the largest existing greenhouses in Canada. With over $75 million already invested into the Delta facility, advanced growing technologies, access to power, and incredible personnel, the retrofit to cannabis production and licensing is anticipated to be swift." He continued, "We are also very pleased to be entering this joint venture as a shareholder of PUF. The fact that we will be acquiring PUF equity at over $2 per share reflects the excellent and exciting suite of assets that the Company has assembled over the past year."
Equity Participation and Subscription
Pursuant to the Agreement, DOCC shall subscribe for and purchase up to 17,832,816 common shares in the capital of PUF (the "Common Shares") at a price of $2.24 per PUF share, representing 19.9% of the issued and outstanding Common Shares of PUF on a fully diluted basis, in consideration for aggregate subscription proceeds of $40,000,000, such proceeds payable on the following draw down schedule:
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
TORONTO, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (“Canada House - CSE: CHV”), one of Canada’s leading vertically integrated provider of medical cannabis products and services, is pleased to announce that it has won a dispensary license from the City of Edmonton through its lottery system. This license will allow for the launch of the non-medical distribution of cannabis and the exploration of other distribution channel opportunities.
The Edmonton based dispensary will have a separate brand identity and is a key component of Canada House’s consulting initiatives, in partnership with Medicine Man Technologies Inc. (OTCQB: MDCL) of Colorado. Not only does this enhance awareness of Canada House by potential micro-grower customers and other Licensed Producers, it should provide new insights into cannabis end users, further expanding Canada House’s licensing and cultivation expertise.
“Canada House is a medical cannabinoid therapy company at the core,” said CHV CEO Chris Churchill-Smith. “We are reviewing and studying the recreational cannabis market and what role CHV can play in it while staying true to our core strategy of providing leading medical cannabinoid therapy products and services. This license allows us to carefully and responsibly test this subsegment of the market while keeping focused on the execution of our clinical strategy. Building on CHV's in-depth understanding of the medical cannabis market, the dispensary enhances CHV's insight and knowledge of the overall cannabis industry by allowing CHV to also track meaningful trends in the recreational market, creating the opportunity to place premium cannabis in both markets.”
Canada House Wellness Group Inc.
CV Sciences, Inc. Announces a New Category of Its Industry-Leading PlusCBD Oil™ Products, Hemp Extract Gummies
LAS VEGAS, Sept. 25, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) preeminent supplier and manufacturer of hemp-derived phytocannabinoids including industry leading brand, PlusCBD Oil™ , announced today that it has introduced PlusCBD Oil™ Gummies at the Natural Product Expo East 2018.
A new category of PlusCBD Oil™ products, PlusCBD Oil™ Gummies are offered in two tasty flavors, Cherry Mango and Citrus Punch. A line extension of our Gold Formula line with no artificial ingredients, each gummy contains 5 mg of CBD and a mere 1.5 g of sugar. Gluten free, vegan friendly, and non-GMO, these new products support healthy balance of the body and mind.
“We are pleased to introduce PlusCBD Oil™ Gummies to our existing line of industry leading hemp extract products that include balms, sprays, drops, capsules, and softgels,” stated Joseph Dowling, Chief Executive Officer of CV Sciences. “We are committed to innovation of our PlusCBD Oil™ products, and as the demand for CBD infused products continues to grow, it is important to expand our wide variety of products to suit all customer preferences. We foresee PlusCBD Oil™ Gummies being a solid revenue driving category for our Company.”
About CV Sciences, Inc. CV Sciences, Inc. (OTCQB:CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and, a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. CV Sciences, Inc. has primary offices and facilities in San Diego, California and Las Vegas, Nevada. Additional information is available from OTCMarkets.com or by visiting www.cvsciences.com.
FORWARD-LOOKING DISCLAIMER This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.
Not for distribution in the U.S. or to U.S. Newswires
VANCOUVER, British Columbia , Sept. 25, 2018 (GLOBE NEWSWIRE) -- BlissCo Cannabis Corp. (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B), (“BlissCo”) or the (“Company”) is pleased to announce that it has completed Health Canada’s pre-sales license inspection of its Greater Vancouver facility.
BlissCo is a wellness-focused, licensed cannabis producer under the Access to Cannabis for Medical Purposes Regulations (the "ACMPR").
Health Canada inspectors were on site at BlissCo’s facility for a number of days last week to verify information submitted by the Company in its sales license amendment application and also to assess compliance. The Pre-Sales License Inspection is the last step required prior to the issuance of a Sales License under the ACMPR.
“Our experience with Health Canada’s inspectors was highly informative and overall very positive. Their team was incredibly thorough and the entire experience was hugely valuable for our team to experience,” said Damian Kettlewell, CEO of BlissCo Cannabis Corp.” We look forward to receiving our pre-sales license inspection report from Health Canada in early October and earning our sales license for dried cannabis flower in the near future. As well, our team is working diligently to submit our cannabis oil sales license amendment to Health Canada in October.” The Company also announces that Navdeep Dhaliwal has resigned from BlissCo's board following his appointment to the role of CEO for The Supreme Cannabis Company.
VANCOUVER, BRITISH COLUMBIA, Sept. 25, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE: FFT) (OTCQB: FFRMF) is on track to begin harvest operations in mid-October at its hemp farms in Hersey and Amity, Maine. With robust plant health and an enterprise-wide commitment to maintaining the Hersey farm’s organic certification, the Company has purchased new equipment and is in the process of obtaining new drying and curing facilities in anticipation of its inaugural harvest. In addition, three-and-a-half acres of Future Farm’s land in Amity are dedicated to the cultivation of feminized, high-CBD seeds of the Cherry Wine varietal.
“We are proud to report that our Hersey farm is healthy and one of the largest operating hemp farms in Maine; we are also very happy with the potential represented by the feminized seeds we expect to harvest in Amity,” said William Gildea, CEO of Future Farm. “Our team’s focus and commitment to high standards have us on track for our first harvest in mid-October.”
For further information, contact Investor Relations at email@example.com or (888) 387-3761 Ext. 710.
On behalf of the Board,
Future Farm Technologies Inc.
Chief Operating Officer Beth Stavola to Share Insights on Emerging Cannabis Market
TORONTO, Sept. 25, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE: MPX; OTC: MPXEF) announced that Beth Stavola, Chief Operating Officer of MPX, will be speaking at the ‘Cannabis and the Capital Markets’ panel at the Cannabis World Congress Business Expo (CWCBE) being held on Thursday, September 27, 2018 at the Los Angeles Convention Center in downtown Los Angeles.
Business opportunities in the cannabis industry are at an all-time high as the market is developing on a global level. There are still many layers to success in this industry and one of its leading voices, Beth Stavola, will provide industry insights to the panel addressing the pitfalls, opportunities, and lessons learned from the process of going public as a cannabis company in the United States and Canada.
The panel of speakers will be moderated by Lewis Goldberg, Managing Partner of KCSA Strategic Communications, and will include Kris Krane, President and Co-Founder, 4Front; Tahira Rehmattulah, Chief Financial Officer, MTech Acquisition Corp. and Managing Director, Hypur Ventures; William Simpson, CEO, Golden Leaf Holdings (CSE: GLH) (OTCQB: GLDFF) and Beth Stavola; c-suite executives of leading cannabis companies who have recently gone public or are in the process of going public.
“Taking a company from private to public is already a very challenging process, let alone attempting to do so in the cannabis industry,” said Mrs. Stavola. “This panel considers all factors along the continuum of growing the industry and outlines strategies for effectively growing a cannabis company, providing a vital educational resource for entrepreneurs looking to enter the industry.”
TORONTO, Sept. 25, 2018 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to congratulate the team at Shoppers Drug Mart on securing a cannabis production licence from Health Canada. This licence allows Canada’s largest pharmacy chain to receive, label and test medical cannabis supplied by WeedMD and represents an important milestone for both companies.
“As one of the most trusted names in pharmacy and patient support services, we congratulate Shoppers Drug Mart on clearing the first step to expanding its offerings and patient accessibility to premium medical cannabis,” said Keith Merker, CEO of WeedMD. “We’re proud to be one of the few trusted and validated supply partners selected by Shoppers Drug Mart to provide medical cannabis and deliver WeedMD’s proprietary education platform to its pharmacists and medical experts.”
Shoppers Drug Mart’s production licence follows WeedMD’s announcement on June 20, 2018 whereby the Company confirmed it was one of few licensed producers to have entered into a supply agreement with the pharmacy. Under the terms of the agreement, the Company will supply WeedMD-branded medical cannabis products to Shoppers Drug Mart and it is expected that the products will be sold online as Canadian regulations currently restrict the sale of medical cannabis in retail pharmacies.
For more information, access WeedMD’s investor presentation here and recently updated corporate video here.
About WeedMD Inc.
NAPANEE, Ontario, Sept. 25, 2018 (GLOBE NEWSWIRE) -- VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF) (“VIVO” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Canna Farms Ltd. (“Canna Farms”) has fulfilled and shipped its first recreational cannabis purchase destined for the British Columbia Liquor Distribution Branch’s (“BCLDB”) warehouse.
Dan Laflamme, President of Canna Farms, said, “It was satisfying for Canna Farms to ship this first, historic shipment of recreational cannabis. We fulfilled the BCLDB’s purchase order on time and in accordance with our plans and processes. We look forward to making similar shipments in the next few weeks to Yukon, Alberta, Saskatchewan, Manitoba, and Ontario from our production facilities in Hope, British Columbia. The world is watching Canada as we lead the way globally in creating a federally regulated adult-use cannabis market”
About VIVO Cannabis™
VIVO, based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licences from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical™, FIRESIDE™, Canna Farms™ and Lumina™. In August 2018, VIVO acquired Canna Farms Limited, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.’s first Licensed Producer and has many years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow. VIVO is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. In addition, VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics. Harvest Medicine provides best-in-class education and support to over 15,000 patients in its clinics and via its free telemedicine platform. VIVO has a healthy balance sheet with over $100 million in cash and is well-positioned to accelerate the growth of its business, in Canada and internationally.
ON BEHALF OF THE BOARD OF DIRECTORS